Home / Health / First Living Patient Receives Pig Kidney
First Living Patient Receives Pig Kidney
3 Jul
Summary
- A cloned, gene-edited pig kidney was successfully transplanted into a human.
- The patient, Towana Looney, was discharged from the hospital in under two weeks.
- Ethical concerns and pandemic risks surround animal-to-human organ transplants.
A pioneering xenotransplant surgery has seen a living patient receive a genetically modified pig kidney. The recipient, Towana Looney, a 53-year-old grandmother, had been on dialysis for nearly a decade after her own kidney failed.
The transplant utilized a cloned pig kidney with ten genetic modifications designed to prevent rejection and ensure compatibility. This procedure, considered highly experimental, was performed under a compassionate use case granted by the FDA due to Looney's unique medical needs.
Surgeons performed the transplant at NYU Langone Health, with the pig kidneys arriving by helicopter during the operation. Looney demonstrated a positive recovery, being discharged from the hospital less than two weeks post-surgery.
While this event offers immense hope for organ transplant patients, it also raises significant ethical concerns and fears of potential zoonotic disease transmission. Bioethicists worry about the lack of extensive scientific evidence and the potential exploitation of vulnerable patients.
Despite these controversies, Looney expressed immense gratitude, reporting a significant improvement in her quality of life. Doctors remain cautiously optimistic about the long-term success of the transplanted organ, acknowledging uncharted territory in this field.
